Plant canopy that a medical cannabis combination business may use to cultivate cannabis that will be sold as medical cannabis flower or medical cannabinoid products increased.
Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision
Manufacture of certain products for sale outside of Minnesota provided, tetrahydrocannabivarin designated as a nonintoxicating cannabinoid, potency limits modified, social equity ownership requirements lowered to 51 percent, manufacturing limits established, and cannabis cultivator license authorizations clarified.